SCG2 and hereditary pheochromocytoma-paraganglioma: Our data suggested that EM66 could potentially be a new diagnostic and prognostic marker of pheochromocytomas, and that, besides CgA, other granin-derived peptides, such as EM66, could represent valuable supplementary markers for the management and follow-up of these tumors.